2024-12-01 2025-11-30 false No description of principal activity Capium Accounts Production 1.1 07858986 2024-12-01 2025-11-30 07858986 bus:FullAccounts 2024-12-01 2025-11-30 07858986 bus:Micro-entities 2024-12-01 2025-11-30 07858986 bus:AuditExempt-NoAccountantsReport 2024-12-01 2025-11-30 07858986 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 07858986 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 07858986 2024-12-01 2025-11-30 07858986 2025-11-30 07858986 bus:RegisteredOffice 2024-12-01 2025-11-30 07858986 core:WithinOneYear 2025-11-30 07858986 core:AfterOneYear 2025-11-30 07858986 1 2024-12-01 2025-11-30 07858986 bus:Director1 2024-12-01 2025-11-30 07858986 bus:Director1 2025-11-30 07858986 bus:Director1 2023-12-01 2024-11-30 07858986 2023-12-01 07858986 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 07858986 2023-12-01 2024-11-30 07858986 2024-11-30 07858986 core:WithinOneYear 2024-11-30 07858986 core:AfterOneYear 2024-11-30 07858986 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 07858986 bus:OrdinaryShareClass1 2024-12-01 2025-11-30 07858986 bus:OrdinaryShareClass1 2025-11-30 07858986 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 07858986 bus:OrdinaryShareClass1 2024-11-30 07858986 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 07858986 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 07858986 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 07858986 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 07858986 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 07858986 core:Non-currentFinancialInstruments 2025-11-30 07858986 core:Non-currentFinancialInstruments 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 07858986
England and Wales
LAWIN-O'BRIEN LIMITED
Unaudited Financial Statements
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

Lawin-O'Brien Limited Contents Page For the year ended 30 November 2025
Company information | 1
Balance sheet | 2

Lawin-O'Brien Limited Company Information For the year ended 30 November 2025
Director | Dr Benjamin O'Brien
Registered Number | 07858986
Registered Office | 74 Highbury Hill London N5 1AP
Accountants | Ludlow Painter Limited Produce House 1a Wickham Court Road West Wickham Kent BR4 9LN
1

Lawin-O'Brien Limited Balance Sheet As at 30 November 2025
|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ | £ |  | £ | £
Current assets |  | 6,242 |  |  | 4,051 |
Creditors: amount falling due within one year |  | (44,062) |  |  | (43,816) |
Net current assets |  |  | (37,820) |  |  | (39,765)
Total assets less current liabilities |  |  | (37,820) |  |  | (39,765)
Net assets |  |  | (37,820) |  |  | (39,765)
Capital and reserves |  |  | (37,820) |  |  | (39,765)
NOTES TO THE ACCOUNTS General Information Lawin-O'Brien Limited is a private company, limited by shares, registered in England and Wales, registration number 07858986, registration address 74 Highbury Hill, London, N5 1AP. The presentation currency is £ sterling.
1. | Average number of employees Average number of employees during the year was 0 (2024 : 0).
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's Responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 05 May 2026 and were signed by:
-------------------------------- Dr Benjamin O'Brien Director
2